Eye disease study aims to pave way for future treatments
NCT ID NCT03146078
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study follows 127 people with a genetic eye condition called USH2A-related retinal degeneration, which can cause vision loss and hearing problems. Researchers measure changes in vision, retinal sensitivity, and mobility over several years. The goal is to understand how the disease progresses so that future treatments can be tested more effectively. No new drugs or treatments are given in this study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA 39 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor Eye Physicians and Surgeons
Houston, Texas, 77030, United States
-
Centre hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, 75012, France
-
Hospital for Sick Children
Toronto, Canada
-
Kellogg Eye Center, University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
-
Moorfields Eye Hospital
London, United Kingdom
-
Moran Eye Center, University of Utah
Salt Lake City, Utah, 84107, United States
-
OHSU Casey Eye Institute
Portland, Oregon, 97239, United States
-
Radboud University
Nijmegen, Netherlands
-
Retina Foundation of the Southwest
Dallas, Texas, 75231, United States
-
University of California, San Francisco
San Francisco, California, 94143-0344, United States
-
University of Tubingen
Tübingen, Germany
-
Vitreo-Retinal Associates
Gainesville, Florida, 32607, United States
-
Wilmer Eye Institute at Johns Hopkins
Baltimore, Maryland, 21287-9277, United States